Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancers of the bladder.

N Sengupta1, Emad Siddiqui, Faiz H Mumtaz

  • 1Department of Urology, Chase Farm Hospital, The Ridgeway, Enfield EN2 8JL, England.

The Journal of the Royal Society for the Promotion of Health
|October 21, 2004
PubMed
Summary

Bladder cancer, a common malignancy strongly linked to smoking, requires ongoing research. The focus is on preventing superficial cases from progressing to invasive or metastatic stages, improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fezolinetant effect on vasomotor symptoms due to menopause in women unsuitable for hormone therapy.

Current medical research and opinion·2025
Same author

Validation and Application of Thresholds to Define Meaningful Change in Vasomotor Symptoms Frequency: Analysis of Pooled SKYLIGHT 1 and 2 Data.

Advances in therapy·2024
Same author

Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause.

Maturitas·2024
Same author

Correction to: Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause.

Advances in therapy·2024
Same author

Treating moderate-to-severe menopausal vasomotor symptoms with fezolinetant: analysis of responders using pooled data from two phase 3 studies (SKYLIGHT 1 and 2).

Menopause (New York, N.Y.)·2024
Same author

Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause.

Advances in therapy·2024

Area of Science:

  • Oncology
  • Urology

Background:

  • Bladder cancer is a prevalent malignancy in Europe and the US.
  • Smoking is a significant risk factor, quadrupling incidence in smokers.
  • Disease severity ranges from superficial to metastatic, impacting prognosis.

Purpose of the Study:

  • To investigate strategies for preventing bladder cancer progression.
  • To reduce recurrence rates and the need for repeated interventions.
  • To improve the management of superficial bladder cancer.

Main Methods:

  • Endoscopic tumor resection for superficial bladder cancer.
  • Intravesical instillation of cytotoxic agents post-resection.
  • Ongoing research into novel preventative therapies.

Main Results:

  • Superficial bladder cancer managed with resection and intravesical therapy.
  • High recurrence rates necessitate frequent monitoring and procedures.
  • Current research aims to block progression to invasive disease.

Conclusions:

  • Effective management of superficial bladder cancer is crucial.
  • Preventing progression to muscle-invasive and metastatic disease is a key research priority.
  • Minimizing recurrence and improving long-term survival remain critical goals.

Related Experiment Videos